Sumi M - Search Results

1

A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.

Kubota N, Miyazawa K, Shoji N, Sumi M, Nakajima A, Kimura Y, Oshiro H, Ebihara Y, Ohyashiki K. Kubota N, et al. Among authors: sumi m. Haematologica. 2003 Sep;88(9):EIM11. Haematologica. 2003. PMID: 12969824 No abstract available.

2

[Chronic myeloid leukemia associated with sustained severe pancytopenia after imatinib mesylate therapy].

Sumi M, Tauchi T, Shimamoto T, Sshida G, Nakajima A, Ito Y, Ohyashiki K. Sumi M, et al. Rinsho Ketsueki. 2002 Sep;43(9):868-70. Rinsho Ketsueki. 2002. PMID: 12412295 Japanese.

3

Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy.

Nakajima A, Tauchi T, Sashida G, Sumi M, Abe K, Yamamoto K, Ohyashiki JH, Ohyashiki K. Nakajima A, et al. Among authors: sumi m. Leukemia. 2003 Mar;17(3):560-7. doi: 10.1038/sj.leu.2402825. Leukemia. 2003. PMID: 12646945

4

Efficacy of SCH66336, a farnesyl transferase inhibitor, in conjunction with imatinib against BCR-ABL-positive cells.

Nakajima A, Tauchi T, Sumi M, Bishop WR, Ohyashiki K. Nakajima A, et al. Among authors: sumi m. Mol Cancer Ther. 2003 Mar;2(3):219-24. doi: 10.4161/cbt.2.3.390. Mol Cancer Ther. 2003. PMID: 12657715

5

Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.

Sashida G, Ohyashiki JH, Nakajima A, Sumi M, Kawakubo K, Tauchi T, Ohyashiki K. Sashida G, et al. Among authors: sumi m. Clin Cancer Res. 2003 Apr;9(4):1489-96. Clin Cancer Res. 2003. PMID: 12684424

6

Natural killer cell lymphoma in the duodenum.

Sumi M, Tauchi T, Sashida G, Kuriyama Y, Nakajima A, Mukai K, Ohyashiki K. Sumi M, et al. Leuk Lymphoma. 2003 Jan;44(1):201-4. doi: 10.1080/1042819021000054706. Leuk Lymphoma. 2003. PMID: 12691165

7

Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.

Tauchi T, Shin-Ya K, Sashida G, Sumi M, Nakajima A, Shimamoto T, Ohyashiki JH, Ohyashiki K. Tauchi T, et al. Among authors: sumi m. Oncogene. 2003 Aug 14;22(34):5338-47. doi: 10.1038/sj.onc.1206833. Oncogene. 2003. PMID: 12917635

8

BCL-2 antisense oligonucleotide genasense is active against imatinib-resistant BCR-ABL-positive cells.

Tauchi T, Sumi M, Nakajima A, Sashida G, Shimamoto T, Ohyashiki K. Tauchi T, et al. Among authors: sumi m. Clin Cancer Res. 2003 Sep 15;9(11):4267-73. Clin Cancer Res. 2003. PMID: 14519654

9

A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.

Kubota N, Miyazawa K, Shoji N, Sumi M, Nakajima A, Kimura Y, Oshiro H, Ebihara Y, Ohyashiki K. Kubota N, et al. Among authors: sumi m. Haematologica. 2003 Nov;88(11):EIM13. Haematologica. 2003. PMID: 14607766 No abstract available.

10

A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.

Sumi M, Tauchi T, Sashida G, Nakajima A, Gotoh A, Shin-Ya K, Ohyashiki JH, Ohyashiki K. Sumi M, et al. Int J Oncol. 2004 Jun;24(6):1481-7. Int J Oncol. 2004. PMID: 15138591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

630 results

Search Page

Filters